Key result
Gradual volume expansion increases MAP ~18 mm Hg in peritoneal dialysis patients, correlating with DLF.
Why the study?
A volume-sensitive inhibitor of [Na,K]ATPase, termed digitalis-like factor (DLF), is postulated to participate in hypertension, but its role in volume expansion in renal failure patients was unclear.
Does volume expansion increase digitalis-like factor activity and blood pressure in end-stage renal failure patients on peritoneal dialysis?
Does volume expansion increase digitalis-like factor activity and blood pressure in end-stage renal failure patients on peritoneal dialysis?
Volume expansion in peritoneal dialysis patients increases a unique volume-sensitive digitalis-like factor that correlates with increased blood pressure, suggesting a mechanism for volume-dependent hypertension.
Answers are grounded in this paper and cite their sources.
Supports DLF as mediator of volume-dependent hypertension in PD; leaves open whether modulating DLF alters outcomes.
A volume-sensitive inhibitor of [Na,K]ATPase, termed the digitalis-like factor (DLF), is postulated to participate in hypertension. To test this hypothesis, end-stage renal failure patients on peritoneal dialysis were placed on a clinical protocol that brought about a gradual, sustained volume expansion. This was accompanied by significant increases in body weight (4.1 +/- 1.2 kg, p < 0.05), mean arterial pressure (18.2 +/- 6.4 mm Hg, p < 0.05), and serum DLF activity (4.7 +/- 1.9% inhibition, p < 0.05). Processing these patients' daily dialysates by ultrafiltration and high-performance liquid chromatography allowed for the identification of a single elution fraction having volume-sensitive [Na,K]ATPase inhibitory activity. This factor in turn was correlated with serum DLF activity (R = 0.60, p = 0.002), weight gain (R = 0.67, p = 0.0003), and mean arterial pressure (R = 0.59, p = 0.003). This factor was readily distinguished from ouabain and digoxin but was similar to the DLF isolated from amniotic fluid. These results suggest that volume expansion in renal failure patients on peritoneal dialysis gives rise to a unique volume-sensitive DLF that may contribute to these patients' increase in blood pressure.
No takes yet. Share an insight, caveat, or question.
Graves et al. (1993) studied End-stage renal failure. Gradual, sustained volume expansion was evaluated on Changes in body weight, mean arterial pressure, and serum digitalis-like factor (DLF) activity (p=<0.05). Gradual volume expansion in peritoneal dialysis patients increased mean arterial pressure and serum DLF activity, which correlated with blood pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: